Six‐year follow‐up of aortic valve reoperation rates: Carpentier‐Edwards Perimount versus St. Jude Medical Trifecta
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cardiac Surgery"
DOI: 10.1111/jocs.15062
Abstract: The Carpentier‐Edwards Perimount valves have a proven track record in aortic valve replacement: good durability, hemodynamic performance, rates of survival, and low rates of valve‐related complications and prosthesis–patient mismatch. The St. Jude Medical Trifecta is… read more here.
Keywords: edwards perimount; perimount; reoperation rates; carpentier edwards ... See more keywords
Eight‐year outcomes of aortic valve replacement with the Carpentier‐Edwards PERIMOUNT Magna Ease valve
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cardiac Surgery"
DOI: 10.1111/jocs.17140
Abstract: The Carpentier‐Edwards PERIMOUNT Magna Ease valve is a third‐generation bioprosthesis for aortic valve replacement (AVR). This is a postapproval study reporting on its 8‐year outcomes. read more here.
Keywords: magna ease; valve; perimount magna; carpentier edwards ... See more keywords
Long-Term Clinical Outcomes of the Carpentier-Edwards Perimount Pericardial Bioprosthesis in Chinese Patients with Single or Multiple Valve Replacement in Aortic, Mitral, or Tricuspid Positions
Sign Up to like & getrecommendations! Published in 2017 at "Cardiology"
DOI: 10.1159/000471478
Abstract: Objectives: To report the safety and efficacy results of a 9- to 15-year follow-up investigation among patients who had received Carpentier-Edwards Perimount (CE-P) bovine pericardial bioprostheses (Edwards Lifesciences, Irvine, CA, USA) for valve replacement. Methods:… read more here.
Keywords: replacement; edwards perimount; term clinical; long term ... See more keywords